Find research datasets worth reusing

Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence

ClinicalTrials.gov study NCT00749658. IPD Sharing: NO. Countries: 1. Publications: 34.

Tocilizumab Real-Life Human Factors (RLHFs) Validation Study

ClinicalTrials.gov study NCT02682823. IPD Sharing: Not stated. Countries: 1. Publications: 1.

A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC

ClinicalTrials.gov study NCT02346370. IPD Sharing: NO. Countries: 1. Publications: 1.

A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or

ClinicalTrials.gov study NCT00875979. IPD Sharing: Not stated. Countries: 7. Publications: 1.

First-Time-in-Human (FTIH) Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of VH4004280 in Healthy Participants

ClinicalTrials.gov study NCT05163522. IPD Sharing: YES. Countries: 1. Publications: 1.

First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors

ClinicalTrials.gov study NCT02937116. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.

A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Lo

ClinicalTrials.gov study NCT01702558. IPD Sharing: Not stated. Countries: 12. Publications: 1.

First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699

ClinicalTrials.gov study NCT03426995. IPD Sharing: YES. Countries: 1. Publications: 1.

A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breas

ClinicalTrials.gov study NCT02131064. IPD Sharing: Not stated. Countries: 10. Publications: 3.

Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)

ClinicalTrials.gov study NCT00048542. IPD Sharing: Not stated. Countries: 8. Publications: 2.

A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Can

ClinicalTrials.gov study NCT01774786. IPD Sharing: Not stated. Countries: 32. Publications: 4.

Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults

ClinicalTrials.gov study NCT03739866. IPD Sharing: NO. Countries: 1. Publications: 1.

A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese Females

ClinicalTrials.gov study NCT00549900. IPD Sharing: YES. Countries: 1. Publications: 1.

First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent

ClinicalTrials.gov study NCT05413668. IPD Sharing: NO. Countries: 1. Publications: 0.

A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

ClinicalTrials.gov study NCT03493542. IPD Sharing: YES. Countries: 1. Publications: 1.

First Time in Human (FTIH) Safety and Pharmacokinetics (PK) Study of GSK3036656 in Healthy Subjects

ClinicalTrials.gov study NCT03075410. IPD Sharing: Not stated. Countries: 1. Publications: 1.

A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HE

ClinicalTrials.gov study NCT01565083. IPD Sharing: Not stated. Countries: 7. Publications: 1.

Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults

ClinicalTrials.gov study NCT02826798. IPD Sharing: NO. Countries: 1. Publications: 19.

A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection

ClinicalTrials.gov study NCT01147302. IPD Sharing: Not stated. Countries: 2. Publications: 1.

A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)

ClinicalTrials.gov study NCT01910402. IPD Sharing: YES. Countries: 13. Publications: 1.